Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T23:43:01.762Z Has data issue: false hasContentIssue false
  • English
  • Français

Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis

Published online by Cambridge University Press:  30 May 2022

Sara Alnajjar Open the ORCID record for Sara Alnajjar [Opens in a new window] ,
Juan Fco. Idiaquez Rios ,
Davood Fathi ,
Geoffrey Liu  and
Vera Bril Open the ORCID record for Vera Bril [Opens in a new window]
Sara Alnajjar
Affiliation:
Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Canada
Juan Fco. Idiaquez Rios
Affiliation:
Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Canada
Davood Fathi
Affiliation:
Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Canada
Geoffrey Liu
Affiliation:
Division of Medical Oncology, The Princess Margaret Cancer Centre/University of Toronto, Canada
Vera Bril*
Affiliation:
Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Canada
*
Corresponding Author: Vera Bril, 5EC-309, Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, M5G 2C4 Canada. Email: vera.bril@utoronto.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

ThymomaAutonomic neuropathyAcetylcholine receptor antibodies
Type
Letter to the Editor: New Observation
Information
Canadian Journal of Neurological Sciences , Volume 50 , Issue 4 , July 2023 , pp. 640 - 641
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, NE, Hutchinson, DO, Nicholson, GJ, Aitcheson, F, Nixon, JM. Intestinal pseudo-obstruction, myasthenia gravis, and thymoma. Neurol. 1996;47:985–87. doi: 10.1212/wnl.47.4.985.CrossRefGoogle ScholarPubMed
Pande, R, Leis, AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve. 1999;22:1600–602. doi: 10.1002/(sici)1097–4598(199911)22:11<1600::aid-mus19>3.0.co;2–3.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Mandl, P, Kiss, JP. Role of presynaptic nicotinic acetylcholine receptors in the regulation of gastrointestinal motility. Brain Res Bull. 2007;72:194–200. doi: 10.1016/j.brainresbull.2007.02.005.CrossRefGoogle ScholarPubMed
Vernino, S, Low, PA, Fealey, RD, Stewart, JD, Farrugia, G, Lennon, VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–55. doi: 10.1056/NEJM200009213431204.CrossRefGoogle ScholarPubMed
Dhamija, R, Tan, KM, Pittock, SJ, Foxx-Orenstein, A, Benarroch, E, Lennon, VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008;6:988–92. doi: 10.1016/j.cgh.2008.04.009.CrossRefGoogle ScholarPubMed
Vernino, S, Cheshire, WP, Lennon, VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001;88:187–92. doi: 10.1016/S1566-0702(01)00239-9.CrossRefGoogle ScholarPubMed
Gerzanich, V, Peng, X, Wang, F, et al. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol. 1995;48:774–82.Google ScholarPubMed
Gilhus, NE, Tzartos, S, Evoli, A, Palace, J, Burns, TM, Verschuuren, JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30. doi: 10.1038/s41572-019-0079-y.CrossRefGoogle ScholarPubMed
Tamburella, C, Parisi, S, Lillo, S, et al. Gastroparesis, thymoma, and asymptomatic myasthenia: a rare clinical scenario. Gastroenterology Insights. 2022;13:27–32. doi: 10.3390/gastroent13010004.CrossRefGoogle Scholar
Parisi, S, Napoli, I, Lillo, S, et al. Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone. J Oncol Pharm Pract. 2022;28:237–41. doi: 10.1177/10781552211027348.CrossRefGoogle Scholar
Sindoni, A, Severo, C, Vadala’, RE, et al. Levetiracetam-induced radiation recall dermatitis in a patient undergoing stereotactic radiotherapy. J Dermatol. 2016;43:1440–441. doi: 10.1111/1346-8138.13427.CrossRefGoogle Scholar